Novel research indicate that Retatru tide , a dual agonist targeting GLP-1 and glucose-dependent insulinotropic peptide receptors , may represent a significant breakthrough within weight reduction. https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide